International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 14: [Related article:] 2177–2185, 2017; DOI: 10.3892/ol.2017.6442
Following the publication of the above article, an interested reader drew to the authors' attention that, concerning the mRNA electrophoretic blots shown in Fig. 5A on p. 2182, the middle and right-hand blots for Cyclin D1 were similar to the left-hand and middle blots for Caspase 9; in addition, the left-hand Cyclin D1 blot was similar to the right-hand blot for GAPDH in the same figure part.
In response to the reader's enquiry, the authors have submitted a revised version of Fig. 5, now showing alternative data for the Cyclin D1 and GAPDH experiments in Fig. 5A, as presented below. The authors can confirm that any errors associated with this figure did not have a significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused.